News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
OSBORNE DAVID W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 690 shares
@ $15.2634, valued at
$10.5k
|
|
| 03/06/2023 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 14,900 shares
@ $0
Granted 39,500 options to buy
@ $15.82, valued at
$624.9k
|
|
| 03/02/2023 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 792 shares
@ $16.1663, valued at
$12.8k
Sold 1,198 shares
@ $15.8185, valued at
$19k
Sold 15 shares
@ $16.52, valued at
$247.8 |
|
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2022 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 2,197 shares
@ $20.4243, valued at
$44.9k
|
|
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $30, valued at
$450k
|
|
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 12,000 options to buy
@ $27.61, valued at
$331.3k
|
|
| 02/04/2020 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Converted 24,991 shares
@ $0
Converted 24,991 preferred shares
@ $0 |
|
| 01/30/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|